 Sequential high-dose methotrexate fluorouracil doxorubicin step treatment advanced gastric cancer trial European Organization Research Treatment Cancer Gastrointestinal Tract Cooperative Group prospective phase III multicenter trial patients advanced measurable nonmeasurable gastric cancer methotrexate MTX fluorouracil Adriamycin doxorubicin Farmitalia Carlo Erba Milan Italy FAMTX Adriamycin mitomycin FAM results superior response rate survival median weeks weeks FAMTX cumulative thrombocytopenia FAM FAMTX FAMTX protocol reference treatment future clinical trials therapeutic outcome advanced gastric cancer